Shares of ResMed Inc. RMD advanced 1.40% to $231.67 Friday, on what proved to be an all-around positive trading session for ...
Shares of ResMed Inc. RMD dropped 0.09% to $228.48 Thursday, on what proved to be an all-around rough trading session for the ...
Zacks.com on MSN13h
ResMed Gains 37.8% in a Year: What's Driving the Stock?ResMed Inc. RMD has witnessed strong momentum in the past year. Shares of the company have risen 37.8% compared with 10.7% ...
Hosted on MSN8h
ResMed's Quarterly Earnings Preview: What You Need to KnowBased in San Diego, California, ResMed Inc. (RMD) develops, manufactures, distributes, and markets medical devices and ...
Highlights,ResMed's stock price dips below its 200-day moving average.,The company posted strong quarterly earnings, ...
Goldman Sachs has a buy rating and $36.20 price target on Woolworths' shares. Analysts at Catapult Wealth are positive on ...
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) has released an update.Don't Miss Our New Year's ...
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) has released an update.Don't Miss Our New Year's ...
ResMed actually specializes in ventilators, for example against sleep apnoea. Now comes the first end customer product for ...
During five years of share price growth, ResMed achieved compound earnings per share (EPS) growth of 21% per year. This EPS growth is higher than the 8% average annual increase in the share price.
Zacks.com on MSN10h
Will ResMed (RMD) Beat Estimates Again in Its Next Earnings Report?ResMed (RMD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback